Rocklatan Alternatives Compared
Rocklatan (latanoprost / netarsudil) | Latanoprost ophthalmic | Timolol ophthalmic |
|
---|
Rocklatan (latanoprost / netarsudil) | Latanoprost ophthalmic | Timolol ophthalmic |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Glaucoma - Open Angle, Intraocular Hypertension. Rocklatan may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Glaucoma - Open Angle, Intraocular Hypertension. Latanoprost ophthalmic may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Glaucoma - Open Angle, Intraocular Hypertension. Timolol ophthalmic may also be used for purposes not listed in this medication guide. |
Related suggestions Glaucoma, Open Angle
Intraocular Hypertension
|
|||||||||||||||||||||||
More about Rocklatan (latanoprost / netarsudil) | More about Latanoprost ophthalmic | More about Timolol ophthalmic | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Rocklatan has an average rating of 4.8 out of 10 from a total of 24 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 50% reported a negative effect. |
Latanoprost ophthalmic has an average rating of 5.1 out of 10 from a total of 72 ratings on Drugs.com. 31% of reviewers reported a positive effect, while 39% reported a negative effect. |
Timolol ophthalmic has an average rating of 6.1 out of 10 from a total of 15 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 27% reported a negative effect. |
||||||||||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Rocklatan side effects |
View all Latanoprost ophthalmic side effects |
View all Timolol ophthalmic side effects |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Rocklatan prices |
View all Latanoprost ophthalmic prices |
View all Timolol ophthalmic prices |
||||||||||||||||||||||||
Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
N/A |
Iyuzeh, Xalatan, Xelpros | Betimol, Istalol, Timoptic, Timoptic Ocudose, Timoptic-XE | ||||||||||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 7 drugs are known to interact with Rocklatan:
|
A total of 7 drugs are known to interact with Latanoprost ophthalmic:
|
A total of 278 drugs are known to interact with Timolol ophthalmic:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
September 12, 2018 |
November 04, 1993 |
||||||||||||||||||||||||
WADA Class View classifications | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient Resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.